http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2275104-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcf8a2b940ece930a864c5f9647e1417
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2010-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7d98aa40372436550fc2544ba87525
publicationDate 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2275104-A3
titleOfInvention Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid
abstract Pharmaceutical and cosmetic compositions for topical use comprising Lactoferrin, Ciclopirox and/or salts thereof, Etidronic Acid and/or salts thereof and use of said compositions in the treatment of dermatological disorders and conditions such as seborrheic dermatitis and dandruff.
priorityDate 2009-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003277221-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007100555-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008095796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007144613-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054818-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9802138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003089629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008038219-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129216178
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCK9IMD0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127711966
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02788
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14632
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29477
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17002
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398723
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2749
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID379502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613079
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TUM0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420889
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24627

Total number of triples: 60.